Multilabo - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 414,873 | 2,263,308 | 2,972,294 | 2,853,019 | 4,784,931 | 5,446,356 | 7,075,467 | 7,298,035 |
| Profit before tax | 19,479 | 31,712 | 72,745 | 6,420 | 126,407 | 641,348 | 735,820 | 183,471 |
| Net profit | 16,181 | 24,717 | 61,773 | 4,228 | 106,021 | 550,541 | 621,992 | 173,788 |
| Equity | 25,864 | 50,581 | 112,354 | 116,592 | 222,614 | 773,155 | 1,395,147 | 1,568,935 |
| Liabilities | 182,310 | 257,118 | 953,595 | 754,072 | 549,896 | 173,884 | 198,093 | 184,062 |
| Non-current assets | 34,345 | 45,465 | 35,530 | 35,852 | 7,570 | 17,270 | 15,323 | 21,072 |
| Current assets | 173,829 | 280,507 | 1,064,655 | 892,365 | 777,575 | 991,289 | 1,606,087 | 1,784,472 |
| Total assets | 208,174 | 325,972 | 1,100,185 | 928,217 | 785,145 | 1,008,559 | 1,621,410 | 1,805,544 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 115,382 | - |
| Social insurance contributions | - | - | - | - | - | 103,113 | 128,149 | 140,460 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +102.0% | +445.5% | +31.3% | -4.0% | +67.7% | +13.8% | +29.9% | +3.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.8% | 7.6% | 5.6% | 0.5% | 13.5% | 54.6% | 38.4% | 9.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 62.6% | 48.9% | 55.0% | 3.6% | 47.6% | 71.2% | 44.6% | 11.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.9% | 1.1% | 2.1% | 0.1% | 2.2% | 10.1% | 8.8% | 2.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 4.7% | 1.4% | 2.4% | 0.2% | 2.6% | 11.8% | 10.4% | 2.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 7.0 | 5.1 | 8.5 | 6.5 | 2.5 | 0.2 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 56,574 | 179,866 | 211,051 | 182,107 | 341,781 | 391,354 | 540,801 | 648,714 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Multilabo - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-18 | 2025-03-13 | 159.50 |
| 2025-02-05 | 2025-02-12 | 1217.09 |
| 2025-02-04 | 2025-02-04 | 988.15 |
| 2025-01-16 | 2025-02-03 | 1217.09 |
| 2025-01-02 | 2025-01-13 | 1968.17 |
| 2024-12-22 | 2024-12-31 | 1968.17 |
| 2024-12-17 | 2024-12-20 | 1968.17 |
| 2024-12-10 | 2024-12-11 | 2671.35 |
| 2024-12-09 | 2024-12-09 | 2619.48 |
| 2024-11-18 | 2024-12-08 | 2671.35 |
| 2024-10-29 | 2024-11-13 | 3462.71 |
| 2024-10-28 | 2024-10-28 | 3371.94 |
| 2024-10-16 | 2024-10-27 | 3462.71 |
| 2024-09-17 | 2024-10-13 | 4133.28 |
| 2024-08-19 | 2024-09-10 | 4799.29 |
| 2024-07-16 | 2024-08-13 | 5470.48 |
| 2024-06-18 | 2024-07-11 | 6138.28 |
| 2024-05-16 | 2024-06-12 | 6803.91 |
| 2024-04-16 | 2024-05-13 | 7521.48 |
| 2024-03-18 | 2024-04-11 | 8238.56 |
| 2024-02-19 | 2024-03-12 | 8928.93 |
| 2024-02-12 | 2024-02-18 | 1075.29 |
| 2024-01-16 | 2024-02-11 | 9740.29 |
| 2024-01-15 | 2024-01-15 | 1351.12 |
| 2023-12-18 | 2024-01-11 | 9916.12 |
| 2023-12-14 | 2023-12-17 | 2409.06 |
| 2023-11-16 | 2023-12-13 | 10584.06 |
| 2023-11-14 | 2023-11-15 | 2313.49 |
| 2023-10-17 | 2023-11-13 | 11278.49 |
| 2023-10-12 | 2023-10-16 | 4323.11 |
| 2023-09-18 | 2023-10-11 | 12038.11 |
| 2023-09-13 | 2023-09-17 | 3770.46 |
| 2023-08-17 | 2023-09-12 | 12703.46 |
| 2023-08-14 | 2023-08-16 | 2306.74 |
| 2023-07-18 | 2023-08-13 | 13471.74 |
| 2023-07-13 | 2023-07-17 | 4594.79 |
| 2023-06-16 | 2023-07-12 | 14159.79 |
| 2023-06-13 | 2023-06-15 | 5211.77 |
| 2023-05-16 | 2023-06-12 | 14826.77 |
| 2023-05-11 | 2023-05-15 | 5697.29 |
| 2023-05-02 | 2023-05-10 | 15562.29 |
| 2023-04-18 | 2023-04-28 | 15562.29 |
| 2023-04-13 | 2023-04-17 | 4042.85 |
| 2023-03-16 | 2023-04-12 | 16257.85 |
| 2023-03-14 | 2023-03-15 | 8828.27 |
| 2023-02-21 | 2023-03-13 | 16943.27 |
| 2023-02-17 | 2023-02-20 | 16943.27 |
| 2023-02-14 | 2023-02-16 | 9520.37 |
| 2023-02-06 | 2023-02-13 | 17635.37 |
| 2023-01-17 | 2023-02-03 | 17635.37 |
| 2023-01-13 | 2023-01-16 | 10279.74 |
| 2022-12-16 | 2023-01-12 | 18444.74 |
| 2022-12-14 | 2022-12-15 | 11153.55 |
| 2022-11-21 | 2022-12-13 | 19118.55 |
| 2022-11-17 | 2022-11-18 | 19118.55 |
| 2022-11-11 | 2022-11-16 | 11221.89 |
| 2022-10-18 | 2022-11-10 | 19786.89 |
| 2022-10-13 | 2022-10-17 | 12383.58 |
| 2022-09-16 | 2022-10-12 | 20498.58 |
| 2022-09-14 | 2022-09-15 | 13018.94 |
| 2022-08-23 | 2022-09-13 | 21183.94 |
| 2022-08-12 | 2022-08-22 | 13176.41 |
| 2022-07-18 | 2022-08-11 | 21941.41 |
| 2022-07-14 | 2022-07-17 | 14528.78 |
| 2022-06-16 | 2022-07-13 | 22693.78 |
| 2022-06-14 | 2022-06-15 | 15363.15 |
| 2022-05-17 | 2022-06-13 | 23150.57 |
| 2022-05-16 | 2022-05-16 | 15075.25 |
| 2022-05-12 | 2022-05-15 | 15125.25 |
| 2022-04-19 | 2022-05-11 | 23857.36 |
| 2022-04-14 | 2022-04-18 | 15633.18 |
| 2022-03-16 | 2022-04-13 | 24598.18 |
| 2022-03-14 | 2022-03-15 | 18307.68 |
| 2022-02-17 | 2022-03-13 | 25263.18 |
| 2022-02-14 | 2022-02-16 | 18553.34 |
| 2022-01-18 | 2022-02-13 | 26018.34 |
| 2022-01-14 | 2022-01-17 | 18688.67 |
| 2022-01-06 | 2022-01-13 | 26703.67 |
| 2021-12-16 | 2022-01-05 | 26844.15 |
| 2021-12-13 | 2021-12-15 | 19945.00 |
| 2021-11-16 | 2021-12-12 | 27510.00 |
| 2021-11-15 | 2021-11-15 | 20608.07 |
| 2021-10-18 | 2021-11-14 | 28178.48 |
| 2021-10-15 | 2021-10-17 | 21185.29 |
| 2021-09-16 | 2021-10-14 | 28850.29 |
Multilabo - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Multilabo, UAB (code 302325611) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €7.30M and net profit of €173.8K, with a profit margin of 2.4%. Revenue increased by 3.1% year on year and by 34.0% over two years, showing continued top-line growth. The longer trend points to rising sales from €5.45M in 2023 to €7.08M in 2024 and €7.30M in 2025. Profitability, however, weakened materially in 2025 after net profit of €550.5K in 2023 and €622.0K in 2024. At the end of 2025, total assets stood at €1.81M, equity at €1.57M and liabilities at €184.1K, indicating a strongly equity-funded balance sheet. Key ratios for 2025 include ROE of 11.1%, ROA of 9.6%, debt-to-equity of 0.12 and asset turnover of 4.04x. Revenue per employee was €663.5K, while profit per employee was €15.8K.